McKesson Reports Fiscal 2014 First-Quarter Results
McKesson Reports Fiscal 2014 First-Quarter Results
- Revenues of $32.2 billion for the first quarter, up 5%.
- First-quarter GAAP earnings per diluted share of $1.83, up 16%, which included two cents from discontinued operations.
- First-quarter Adjusted Earnings per diluted share from continuing operations of $2.07, up 34%.
- Board of Directors approved raising the quarterly dividend by 20% from 20 cents to 24 cents per share.
- Fiscal 2014 Outlook: Adjusted Earnings per diluted share from continuing operations of $8.05 to $8.35.
SAN FRANCISCO--(BUSINESS WIRE)-- McKesson Corporation (NYS: MCK) today reported that revenues for the first quarter ended June 30, 2013 were $32.2 billion, up 5% compared to $30.7 billion a year ago. On the basis of U.S. generally accepted accounting principles ("GAAP"), first-quarter earnings per diluted share was $1.83 compared to $1.58 a year ago.
First-quarter Adjusted Earnings per diluted share from continuing operations was $2.07, up 34% compared to $1.54 a year ago.
"McKesson is off to an excellent start in Fiscal 2014, with strong execution from both Distribution Solutions and Technology Solutions driving earnings growth," said John H. Hammergren, chairman and chief executive officer. "Based on the momentum from our first-quarter results and our confidence in the full year, we are raising our previous outlook for the fiscal year and now expect Adjusted Earnings per diluted share from continuing operations of $8.05 to $8.35 for the fiscal year ending March 31, 2014."
For the first quarter, McKesson generated cash from operations of $716 million, and ended the quarter with cash and cash equivalents of $2.9 billion and a gross debt-to-capital ratio of 39.7%. During the quarter, McKesson paid $53 million in dividends, had internal capital spending of $100 million, and spent $74 million on acquisitions.
Today, the Board of Directors approved an increase to the quarterly dividend from 20 cents to 24 cents per share.
"Our strong balance sheet and cash flow performance provide us with opportunities to deploy capital to advance our long-term strategic objectives and lay the foundation for future growth," Hammergren commented. "We continue to believe our portfolio approach to capital deployment, through a mixture of acquisitions, share repurchases, dividends and internal capital spending, creates significant value for our shareholders."
As previously announced, the Company is exiting its International Technology and Hospital Automation businesses. Results for these two businesses are reported in discontinued operations in McKesson's condensed statement of operations.
Distribution Solutions revenues were up 5% in the first quarter, driven mainly by strong growth in U.S. pharmaceutical direct distribution and services revenues, reflecting market growth and our mix of business, as well as the acquisition of PSS World Medical, Inc. ("PSS").
Canadian revenues, on a constant currency basis, increased 3% for the first quarter primarily due to market growth. Including an unfavorable currency impact of 1%, Canadian revenues increased 2% for the first quarter.
Medical-Surgical distribution and services revenues were up 71% for the first quarter driven primarily by the acquisition of PSS.
In the first quarter, Distribution Solutions GAAP operating profit was $619 million and GAAP operating margin was 1.97%. First-quarter adjusted operating profit was $700 million and the adjusted operating margin was 2.23%.
Technology Solutions revenues were up 9% in the first quarter compared to the prior year. GAAP operating profit was $119 million for the first quarter and GAAP operating margin was 14.78%. Adjusted operating profit was $137 million for the first quarter and adjusted operating margin was 17.02%.
Fiscal Year 2014 Outlook
McKesson expects Adjusted Earnings per diluted share from continuing operations between $8.05 and $8.35 for the fiscal year ending March 31, 2014, which excludes the following GAAP items:
- Amortization of acquisition-related intangible assets of 75 cents per diluted share.
- Acquisition expenses and related adjustments of 22 cents per diluted share.
- Litigation reserve adjustments of approximately four cents per diluted share.
- LIFO inventory-related charges of 24 cents to 29 cents per diluted share.
McKesson separately reports financial results on the basis of Adjusted Earnings. Adjusted Earnings is a non-GAAP financial measure defined as GAAP income from continuing operations, excluding amortization of acquisition-related intangible assets, acquisition expenses and related adjustments, certain litigation reserve adjustments, and Last-In-First-Out ("LIFO") inventory-related adjustments. A reconciliation of McKesson's financial results determined in accordance with GAAP to Adjusted Earnings is provided in Schedules 2, 3 and 4 of the financial statement tables included with this release. Recasted Adjusted Earnings for Fiscal 2013 is provided in Schedules 7, 8 and 9.
Except for historical information contained in this press release, matters discussed may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These statements may be identified by their use of forward-looking terminology such as "believes", "expects", "anticipates", "may", "will", "should", "seeks", "approximately", "intends", "plans", "estimates" or the negative of these words or other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. It is not possible to predict or identify all such risks and uncertainties; however, the most significant of these risks and uncertainties are described in the company's Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission and include, but are not limited to: material adverse resolution of pending legal proceedings; changes in the U.S. healthcare industry and regulatory environment; changes in the Canadian healthcare industry and regulatory environment; competition; substantial defaults in payment or a material reduction in purchases by, or the loss of, a large customer or group purchasing organization; the loss of government contracts as a result of compliance or funding challenges; public health issues in the U.S. or abroad; malfunction, failure or breach of sophisticated internal information systems to perform as designed; the adequacy of insurance to cover property loss or liability claims; the company's failure to attract and retain customers for its software products and solutions due to integration and implementation challenges, or due to an inability to keep pace with technological advances; the company's proprietary products and services may not be adequately protected, and its products and solutions may be found to infringe on the rights of others; system errors or failure of our technology products and solutions to conform to specifications; disaster or other event causing interruption of customer access to data residing in our service centers; the delay or extension of our sales or implementation cycles for external software products; changes in circumstances that could impair our goodwill or intangible assets; foreign currency fluctuations or disruptions to our foreign operations; new or revised tax legislation or challenges to our tax positions; the company's ability to successfully identify, consummate and integrate strategic acquisitions; general economic conditions, including changes in the financial markets that may affect the availability and cost of credit to the company, its customers or suppliers; and changes in accounting principles generally accepted in the United States of America. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.
The company has scheduled a conference call for 5:00 PM ET. The dial-in number for individuals wishing to participate on the call is 719-234-7317. Erin Lampert, senior vice president, Investor Relations, is the leader of the call, and the password to join the call is 'McKesson'. A replay of this conference call will be available for five calendar days. The dial-in number for individuals wishing to listen to the replay is 888-203-1112 and the pass code is 1098967. A webcast of the conference call will also be available live and archived on the company's Investor Relations website at www.mckesson.com/investors.
Shareholders are encouraged to review SEC filings and more information about McKesson, which are located on the company's website.
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com.
|CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - GAAP|
|(in millions, except per share amounts)|
|Quarter Ended June 30,|
|Cost of sales||(30,288||)||(29,138||)||4|
|Litigation charges (1)||(15||)||(16||)||(6||)|
|Gain on business combination (2)||-||81||-|
|Total operating expenses||(1,273||)||(985||)||29|
|Other income, net||6||8||(25||)|
|Income from continuing operations before income taxes||594||528||13|
|Income tax expense||(174||)||(149||)||17|
|Income from continuing operations||420||379||11|
|Income from discontinued operations, net of tax (3)||4||1||300|
|Earnings per common share (4)|
|Weighted average common shares|
|(1)||Represent charges for the Average Wholesale Price ("AWP") litigation.|
|(2)||For the first quarter of 2013, operating expenses include an $81 million pre-tax ($51 million after-tax) gain on business combination related to the acquisition of the remaining 50% ownership interest in our corporate headquarters building.|
|(3)||Represents our International Technology and Hospital Automation businesses in our Technology Solutions segment and a small business in our Distribution Solutions segment.|
|(4)||Certain computations may reflect rounding adjustments.|
|RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP)|
|(in millions, except per share amounts)|
|Quarter Ended June 30, 2013||Vs. Prior Quarter|
|Other income, net||6||-||-||-||-||6||(25||)||(25||)|
|Income from continuing operations before income taxes||594||71||13||15||-||693||13||35|
|Income tax expense||(174||)||(27||)||(5||)||(6||)||-||(212||)||17||48|
|Income from continuing operations||$||420||$||44||$||8||$||9||$||-||$||481||11||30|
Diluted earnings per common share from continuing operations (1)
|Diluted weighted average common shares||232||232||232||232||-||232||(3||)||%||(3||)||%|
|Quarter Ended June 30, 2012|